澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - rosuvastatin calcium -

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - rosuvastatin calcium -

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - rosuvastatin calcium -

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - rosuvastatin calcium - oral tablet - 10mg

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - rosuvastatin calcium - oral tablet - 10mg

亚美尼亚 - 英文 - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmaceutical works polpharma s.a. - rosuvastatin (rosuvastatin calcium) - tablets film-coated - 10mg

约旦 - 英文 - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

إتقان للصناعات الدوائية - itqan pharmaceutical industries - rosuvastatin (as rosuvastatin calcium)10 mg/1 tab - (as rosuvastatin calcium)10 mg/1 tab

约旦 - 英文 - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

إتقان للصناعات الدوائية - itqan pharmaceutical industries - rosuvastatin (as rosuvastatin calcium)10 mg/1 tab - (as rosuvastatin calcium)10 mg/1 tab

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

viatris limited - rosuvastatin calcium 10.396mg equivalent to rosuvastatin 10 mg - film coated tablet - 10 mg - active: rosuvastatin calcium 10.396mg equivalent to rosuvastatin 10 mg excipient: colloidal silicon dioxide crospovidone iron oxide red lactose monohydrate light magnesium oxide magnesium stearate microcrystalline cellulose opadry pink - rosuvastatin calcium is indicated to: · reduce elevated ldl-c, total cholesterol, triglycerides and to increase hdlcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (fredrickson types iia and iib). rosuvastatin calcium also lowers apob, nonhdl-c, vldl-c, vldl-tg, the ldl-c/hdl-c, total c/hdl-c, nonhdl-c/hdl-c, apob/apoa-i ratios and increase apo-a-i in these populations. · treat isolated hypertriglyceridaemia (fredrickson type iv hyperlipidaemia). · reduce total cholesterol and ldl-c in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or alone if such treatments are unavailable.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rosuvastatin calcium -